As Congress considers drug price reforms, Merck, Lilly and Takeda execs warn of dire consequences
As Congress considers drug price reforms, Merck, Lilly and Takeda [...]
As Congress considers drug price reforms, Merck, Lilly and Takeda [...]
GSK, Pfizer and Johnson & Johnson race toward $10B+ RSV [...]
Citius buys out license to Ontak replacement from Dr. Reddy’s [...]
Teligent pulls ‘super potent’ topical lidocaine lot following failed stability [...]
Crippled by opioid-crisis litigation, Mallinckrodt settlement brings company closer to [...]
AstraZeneca strikes COVID-19 vaccine delivery deal with Europe, ending high-profile [...]
CDC, FDA chiefs push back on White House COVID-19 booster [...]
Meet Neffy, the friendly epinephrine nasal spray from ARS Pharma [...]
With approval for China’s 2nd CAR-T therapy, Juno, WuXi joint [...]
Lilly’s COVID-19 antibody combo cleared for nationwide use as feds [...]